Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy ; volume:22 ; number:1 ; day:9 ; month:8 ; year:2022 ; pages:1-13 ; date:12.2022
BMC cancer ; 22, Heft 1 (9.8.2022), 1-13, 12.2022
- Urheber
-
Wang, Hanyang
Ji, Dengbo
Tian, Huifang
Gao, Zhaoya
Song, Can
Jia, Jinying
Cui, Xinxin
Zhong, Lijun
Shen, Jing
Gu, Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09960-z
- URN
-
urn:nbn:de:101:1-2022102700334255480584
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Hanyang
- Ji, Dengbo
- Tian, Huifang
- Gao, Zhaoya
- Song, Can
- Jia, Jinying
- Cui, Xinxin
- Zhong, Lijun
- Shen, Jing
- Gu, Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study